CoChat
Sign Up
Cited by 162

The DOI matches its Crossref record.

Novel genotype–phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy

Lopes, Luis R, Syrris, Petros, Guttmann, Oliver P, O'Mahony, Constantinos, Tang, Hak Chiaw, Dalageorgou, Chrysoula, Jenkins, Sharon, Hubank, Mike, Monserrat, Lorenzo, McKenna, William J, Plagnol, Vincent, Elliott, Perry M·2015·Heart
DOI 10.1136/heartjnl-2014-306387PMC PMC4345808
Open this paper in CoChat — free account

Abstract

Objective: A predictable relation between genotype and disease expression is needed in order to use genetic testing for clinical decision-making in hypertrophic cardiomyopathy (HCM). The primary aims of this study were to examine the phenotypes associated with sarcomere protein (SP) gene mutations and test the hypothesis that variation in non-sarcomere genes modifies the phenotype. Methods: Unrelated and consecutive patients were clinically evaluated and prospectively followed in a specialist clinic. High-throughput sequencing was used to analyse 41 genes implicated in inherited cardiac conditions. Variants in SP and non-SP genes were tested for associations with phenotype and survival. Results: 874 patients (49.6±15.4 years, 67.8% men) were studied; likely disease-causing SP gene variants were detected in 383 (43.8%). Patients with SP variants were characterised by younger age and higher prevalence of family history of HCM, family history of sudden cardiac death, asymmetric septal hypertrophy, greater maximum LV wall thickness (all p values<0.0005) and an increased incidence of cardiovascular death (p=0.012). Similar associations were observed for individual SP genes. Patients with ANK2 variants had greater maximum wall thickness (p=0.0005). Associations at a lower level of significance were demonstrated with variation in other non-SP genes. Conclusions: Patients with HCM caused by rare SP variants differ with respect to age at presentation, family history of the disease, morphology and survival from patients without SP variants. Novel associations for SP genes are reported and, for the first time, we demonstrate possible influence of variation in non-SP genes associated with other forms of cardiomyopathy and arrhythmia syndromes on the clinical phenotype of HCM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/heartjnl-2014-306387

Cites

Statistics

Figures

Figure 1 Comparison between sarcomere gene mutation-positive and -negative patients. (A) Age at initial evaluation (45.78±14.65 vs 53.05±14.94 years). (B) Family history of hypertrophic cardiomyopathy (HCM). (C) Family history of sudden cardiac death (SCD). (D) Hypertrophy pattern. (E) Maximum wall thickness (18.83±4.42 vs 18.12±4.08 mm). (F) Implanted implantable cardioverter-defibrillators (ICDs). Key: 0: sarcomere-negative; 1: sarcomere-positive. For B, C, E: red colour and percentages indicate the individuals with the trait within each genotype; for D light blue—asymmetric septal hypertrophy; red—apical hypertrophy; green—concentric hypertrophy.
Figure 1 Comparison between sarcomere gene mutation-positive and -negative patients. (A) Age at initial evaluation (45.78±14.65 vs 53.05±14.94 years). (B) Family history of hypertrophic cardiomyopathy (HCM). (C) Family history of sudden cardiac death (SCD). (D) Hypertrophy pattern. (E) Maximum wall thickness (18.83±4.42 vs 18.12±4.08 mm). (F) Implanted implantable cardioverter-defibrillators (ICDs). Key: 0: sarcomere-negative; 1: sarcomere-positive. For B, C, E: red colour and percentages indicate the individuals with the trait within each genotype; for D light blue—asymmetric septal hypertrophy; red—apical hypertrophy; green—concentric hypertrophy.CC BY · PubMed Central
Figure 2 Kaplan–Meier cumulative incidence curves for cardiovascular death (see Methods section), comparing sarcomere-positive and sarcomere-negative individuals, modelled for (A): follow-up from first evaluation (years), log-rank test p value=0.012 (HR 2.81; 95% CI 1.21 to 6.51) and (B): time from birth (years), log-rank test p value=0.001 (HR 3.99; 95% CI 1.71 to 9.36). The Y axis values indicate proportions.
Figure 2 Kaplan–Meier cumulative incidence curves for cardiovascular death (see Methods section), comparing sarcomere-positive and sarcomere-negative individuals, modelled for (A): follow-up from first evaluation (years), log-rank test p value=0.012 (HR 2.81; 95% CI 1.21 to 6.51) and (B): time from birth (years), log-rank test p value=0.001 (HR 3.99; 95% CI 1.71 to 9.36). The Y axis values indicate proportions.CC BY · PubMed Central
Figure 3 Kaplan–Meier cumulative incidence curves for sudden cardiac death/aborted sudden cardiac death, comparing sarcomere-positive and sarcomere-negative individuals, modelled for (A): follow-up from first evaluation (years), log-rank test p value=0.039 (HR 2.89; 95% CI 1.01 to 8.33) and (B): time from birth (years), log-rank test p value=0.028 (HR 3.44; 95% CI 1.19 to 9.92) . The Y axis values indicate proportions.
Figure 3 Kaplan–Meier cumulative incidence curves for sudden cardiac death/aborted sudden cardiac death, comparing sarcomere-positive and sarcomere-negative individuals, modelled for (A): follow-up from first evaluation (years), log-rank test p value=0.039 (HR 2.89; 95% CI 1.01 to 8.33) and (B): time from birth (years), log-rank test p value=0.028 (HR 3.44; 95% CI 1.19 to 9.92) . The Y axis values indicate proportions.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 30

  1. 10.1016/S0140-6736(04)16358-7 · DOI
  2. 10.1016/j.jacc.2011.06.011 · DOI · Paper page
  3. 10.1093/eurheartj/ehq271 · DOI
  4. 10.1016/j.jacc.2012.02.068 · DOI
  5. 10.4065/83.6.630 · DOI
  6. 10.1136/heartjnl-2013-303939 · DOI
  7. Watkins, 1998, Genotype: phenotype correlations in hypertrophic cardiomyopathy, Eur Heart J, 19, 10
  8. 10.1016/S0735-1097(02)01900-9 · DOI
  9. 10.1161/01.CIR.0000042675.59901.14 · DOI
  10. 10.1053/euhj.1997.0575 · DOI
  11. 10.1161/01.CIR.97.22.2230 · DOI
  12. 10.1016/S0735-1097(96)00530-X · DOI
  13. 10.1016/j.jacc.2004.07.045 · DOI
  14. 10.1161/CIRCGENETICS.111.959973 · DOI
  15. 10.1161/CIRCGENETICS.111.960831 · DOI
  16. 10.1016/j.jacc.2004.04.039 · DOI
  17. 10.1093/hmg/ddm202 · DOI · Paper page
  18. 10.1038/ejhg.2012.48 · DOI
  19. 10.1136/jmedgenet-2012-101270 · DOI
  20. 10.1016/S0735-1097(00)01003-2 · DOI
  21. 10.1093/eurheartj/ehm342 · DOI
  22. 10.1136/hrt.77.2.130 · DOI
  23. 10.1136/heartjnl-2012-303271 · DOI
  24. 10.1038/ng.806 · DOI
  25. 10.1016/j.ajhg.2011.03.004 · DOI
  26. 10.1038/ncpcardio1110 · DOI
  27. 10.1016/j.jacc.2009.11.062 · DOI
  28. 10.1016/j.hrthm.2009.09.070 · DOI
  29. 10.1161/CIRCULATIONAHA.111.060343 · DOI
  30. 10.1016/j.yjmcc.2009.04.010 · DOI

Cited by

Sorted by citations

See all 162

Metadata

Authors
Lopes, L. R., Syrris, P., Guttmann, O. P., O'Mahony, C., Tang, H. C., Dalageorgou, C., Jenkins, S., Hubank, M., Monserrat, L., McKenna, W. J., Plagnol, V., & Elliott, P. M.
Venue
Heart
Publisher
BMJ
Published
2014-10-28
Volume
101
Issue
4
Pages
294-301
ISSN
  • 1355-6037
  • 1468-201X
DOI
10.1136/heartjnl-2014-306387
PMC
PMC4345808
Cited by
162
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel genotype–phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy. https://app.cochat.ai/papers/10.1136/heartjnl-2014-306387
The paper
Lopes, L. R., Syrris, P., Guttmann, O. P., O'Mahony, C., Tang, H. C., Dalageorgou, C., Jenkins, S., Hubank, M., Monserrat, L., McKenna, W. J., Plagnol, V., & Elliott, P. M. (2015). Novel genotype–phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy. Heart. https://doi.org/10.1136/heartjnl-2014-306387